Sarepta Therapeutics Inc
Change company Symbol lookup
Select an option...
SRPT Sarepta Therapeutics Inc
BYRG Buyer Group International Inc
AVT Avnet Inc
ALLY Ally Financial Inc
NVFY Nova LifeStyle Inc
CVG Convergys Corp
KMBNY Komercni Banka as
POWR PowerSecure International Inc
TWCI T.W.Christian Inc
FB Facebook Inc
Go

Health Care : Biotechnology | Small Cap BlendCompany profile

Sarepta Therapeutics, Inc. is a biopharmaceutical company. The Company is focused on the discovery and development of ribonucleic acid (RNA)-targeted therapeutics for the treatment of rare, infectious and other diseases. The Company operates in one segment: the development of pharmaceutical products on its own behalf or in collaboration with others. The Company, through its platform technologies, targets a range of diseases and disorders through RNA-targeted mechanisms of action. The Company is also developing therapeutics using its technology for the treatment of drug-resistant bacteria and infectious, rare and other human diseases. The Company's lead Duchenne Muscular Dystrophy (DMD) product candidate, Eteplirsen, is an antisense phosphorodiamidate morpholino oligomer (PMO) therapeutic in Phase III clinical development for the treatment of individuals with DMD having an error in the gene coding for dystrophin that is amenable to skipping exon 51.

Closing Price
$17.22
Day's Change
-0.80 (-4.44%)
Bid
--
Ask
--
B/A Size
--
Day's High
18.36
Day's Low
16.62
Volume
(Light)
Volume:
8,796,323
10-day average volume:
21,511,212
8,796,323
  • Prev Close
    18.02
  • Today's Open
    17.73
  • Day's Range
    16.62-18.36
  • Avg Vol (10-day)
    21.5M
  • Last (time)
    3:59p ET 05/04/16
  • Last (size)
    80
  • 52-Wk Range
    8.00 - 41.97
    LowHigh
  • (10/05/15 - 04/26/16)
    115.25%
  • 143.3%
  • Market Cap
    788.2M
  • Shares Outstanding
    45.8M
  • -5.19
  • --
  • No dividend
  • Ex-dividend
    No dividend
  • 1.6
  • 59.60
  • (% of float 04/15/16)
    43.64

Latest News

May 03, 2016
9:10 am ET
Zacks
May 02, 2016
1:05 pm ET
Zacks
April 28, 2016
9:41 am ET
MarketWatch
9:11 am ET
MarketWatch
8:45 am ET
MarketWatch
8:30 am ET
Zacks
April 27, 2016
3:07 pm ET
Zacks
7:20 am ET
MarketWatch
April 26, 2016
11:36 am ET
Zacks
8:50 am ET
MarketWatch
8:50 am ET
MarketWatch
8:49 am ET
MarketWatch
8:49 am ET
MarketWatch
8:48 am ET
MarketWatch
8:02 am ET
MarketWatch
7:53 am ET
MarketWatch
7:53 am ET
MarketWatch
7:52 am ET
MarketWatch
7:51 am ET
MarketWatch
7:18 am ET
MarketWatch
April 25, 2016
10:58 pm ET
BusinessWire
7:05 am ET
MarketWatch
April 24, 2016
8:25 pm ET
PR Newswire
April 21, 2016
2:26 pm ET
Zacks
April 20, 2016
3:38 pm ET
Zacks
April 07, 2016
10:30 am ET
Zacks
March 16, 2016
11:56 am ET
Zacks
March 15, 2016
4:50 pm ET
Zacks
9:31 am ET
PR Newswire
March 14, 2016
8:30 am ET
BusinessWire
March 08, 2016
5:15 pm ET
BusinessWire
March 01, 2016
9:31 am ET
PR Newswire
February 26, 2016
11:50 am ET
Zacks
February 25, 2016
4:06 pm ET
BusinessWire
February 17, 2016
9:31 am ET
PR Newswire
Go to all current & historical news

Earnings Calendar and Events Data provided by |Terms of Use| © 2016 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by SunGard.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by , Computrade Systems, Inc.,, , and

Copyright © 2016. All rights reserved.